Skip to main content
Toggle navigation
Login
Search
Home
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Favorite
Like
Tweet
Print
Shilpa Madari, MS
Trial Clinical Pharmacologist
Boehringer Ingelheim Intl GmbH
Poster(s):
029: In Vitro & In Vivo Assessment on Endogenous Biomarkers for Studying Renal Transporter (OCT2, MATE1/2-K) Mediated Drug Interaction & Disease Impact Consideration in Novel Endogenous Biomarker, N1-Methyladenosine: A Systematic Review
Sunday, September 10, 2023
5:00 PM - 7:00 PM
PT